NCT00611546

Brief Summary

In an effort to decrease the load of peroxides in TPN solutions, multiple studies examined different strategies such as photo-protection, adding multivitamins to the lipid emulsion rather than to the dextrose-amino acid admixture, and adding antioxidants such as glutathione to the TPN solution. However, the role of trace elements as antioxidants, and their interaction with light have not been studied. Also, the impact of TPN-related oxidants on clinical morbidities has not been addressed. Therefore, we aimed in this study of preterm infants to evaluate the role of different components of TPN on urinary peroxides and to examine the biochemical and clinical effects of light protection.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2003

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2003

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2005

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2005

Completed
3.1 years until next milestone

First Submitted

Initial submission to the registry

January 24, 2008

Completed
18 days until next milestone

First Posted

Study publicly available on registry

February 11, 2008

Completed
Last Updated

February 11, 2008

Status Verified

January 1, 2008

Enrollment Period

1.8 years

First QC Date

January 24, 2008

Last Update Submit

January 28, 2008

Conditions

Keywords

pretermparenteral nutritionTPNlipid emulsionsphoto-protectionoxidative stress

Outcome Measures

Primary Outcomes (1)

  • Concentration of peroxides in the urine

    48 hours

Secondary Outcomes (1)

  • Clinical morbidities (death, and bronchopulmonary dysplasia)

    during hospital stay

Study Arms (2)

1

PLACEBO COMPARATOR

Perenteral nutrition bottle and tubing are not protected from light

Other: Photo-exposure

2

ACTIVE COMPARATOR

Perenteral nutrition bottle and tubing are protected from light

Other: Photo-protection

Interventions

Parenteral solutions are protected from day light using aluminum covers

2

Perenteral nutrition bottles and tubings are allowed to be exposed to day light.

1

Eligibility Criteria

AgeUp to 7 Days
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Preterm infants included are:
  • with gestational age between 28 to 34 weeks
  • managed with TPN as part of their care in the NICU
  • their postnatal age on enrolment was \< 7 days

You may not qualify if:

  • Infants are excluded if they have:
  • Clinical evidence of sepsis, or a positive blood culture on admission
  • Hepatobiliary dysfunction
  • Persistent metabolic acidosis with base deficit \> 10 mEq / L
  • Renal impairment (urine output \< 1 ml/kg/hour and serum creatinine \> 1 mg/dl)
  • Disseminated intravascular coagulopathy
  • Maternal conditions known to be associated with oxidative stress such as preeclampsia, hypertension and diabetes.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Bassiouny MR, Almarsafawy H, Abdel-Hady H, Nasef N, Hammad TA, Aly H. A randomized controlled trial on parenteral nutrition, oxidative stress, and chronic lung diseases in preterm infants. J Pediatr Gastroenterol Nutr. 2009 Mar;48(3):363-9. doi: 10.1097/mpg.0b013e31818c8623.

MeSH Terms

Conditions

Premature BirthHyperphagia

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesSigns and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Mohamed R Bassiouny, MD

    Mansoura University Children's Hospital

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

January 24, 2008

First Posted

February 11, 2008

Study Start

April 1, 2003

Primary Completion

January 1, 2005

Study Completion

January 1, 2005

Last Updated

February 11, 2008

Record last verified: 2008-01